On Demand: 4th Annual RAD Conference - April 9-11, 2022


4th Annual RAD Conference - April 9-11, 2022 - Now Available on Demand!

If you were unable to join us live for the 4th Annual RAD Conference on April 9-11, you may access the scientific sessions on demand now through Friday, May 13, 2022.

  • The on-demand program is not CME/CE accredited.
  • No industry-sponsored sessions will be available.
  • The Registration Fee is US $150.
  • If you previously registered for the live conference, the on-demand is available to you at no charge. Please check your email for information on how to access the on-demand program.

The following sessions (including Q&A) are available on demand:

  • Sunday, April 10, 2022: Mini-Symposia 1-4
  • Monday, April 11, 2022: Late-Breaking Research Session
  • Monday, April 11, 2022: Mini-Symposia 5-7

About RAD

Although diagnosis of Atopic Dermatitis (AD) is straightforward in children, its diagnosis is challenging in adults. Advances in research on AD epidemiology, burden and comorbidities have transformed the understanding of the course of AD, including risk factors, age of onset, disease severity and persistence, and health outcomes. Clinicians may not be aware of the epidemiology of AD for proper risk stratification, patient education and therapeutic decision-making. Atopic dermatitis is a heterogeneous disorder with variable severity of signs and symptoms, and impact on quality of life. Clinicians may not be able to assess AD severity accurately in order to optimize therapy.

Our Conference allows clinicians to understand this disease better through the latest in research, expert faculty speakers, late-breaking research and Q&A sessions.

Target Audience

This program is intended for dermatologists, allergists and immunologists, primary care clinicians, NPs/RNs/APRNs, physician assistants and other allied health professionals as well as patients/patient groups engaged in the care of patients with Atopic Dermatitis (AD).

Educational Objectives

After completing this activity, upon diagnosis and assessment of severity of AD, the participant should be better able to:

  • Use evidence-based treatment approaches for atopic dermatitis
  • Translate improved understanding of pathophysiology, disease course and current, available treatment options to therapeutic decision making for atopic dermatitis and related comorbidities
  • Describe the remaining unmet needs in the treatment of atopic dermatitis
  • Discuss emerging therapies in the treatment of atopic dermatitis


The cost to register for this program is US $150. Upon completing your registration and payment, you will receive an email confirming your registration as well as a link to view the program. Please allow 15 minutes after registering before you access the program in order to allow time for your registration to process.

If you are a student, resident or patient, and you are interested in viewing the program, please contact Donna Jimenez: djimenez@dnadigitalgroup.com

If you registered for the program and did not receive your registration confirmation with the link to access the program, please check your spam/junk folder. If you are unable to find the email, please contact Donna Jimenez: djimenez@dnadigitalgroup.com